Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

  • Franck Morschhauser*
  • , Martin J.S. Dyer
  • , Harriet S. Walter
  • , Alexey V. Danilov
  • , Loic Ysebaert
  • , Daniel James Hodson
  • , Christopher Fegan
  • , Simon A. Rule
  • , John Radford
  • , Guillaume Cartron
  • , Krimo Bouabdallah
  • , Andrew John Davies
  • , Stephen Spurgeon
  • , Nishanthan Rajakumaraswamy
  • , Biao Li
  • , Rita Humeniuk
  • , Xi Huang
  • , Pankaj Bhargava
  • , Juliane M. Jürgensmeier
  • , Gilles Salles
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2108-2113
Number of pages6
JournalLeukemia
Volume35
Issue number7
DOIs
Publication statusPublished - Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this